JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.

Benyoucef A, Haigh K, Cuddihy A, Haigh JJ
Leukemia. 2022 Dec;36(12):2802-2816. doi: 10.1038/s41375-022-01716-9. Epub 2022 Oct 13. (Link opens in a new window) PubMed (Link opens in a new window) Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.